Optimizing Display, Analysis, Interpretation and Utility of Self-Monitoring of Blood Glucose (SMBG) Data for Management of Patients with Diabetes

Background: Self-monitoring of blood glucose (SMBG) data have not been used to fullest advantage. Few physicians routinely download data from memory-equipped glucose meters and perform systematic analyses and interpretation of the data. There is need for improved methods for display and analysis of SMBG data, for a systematic approach for identification and prioritization of clinical problems revealed by SMBG, for characterization of blood glucose variability, and for clinical decision support. Methods: We have developed a systematic approach to the analysis and interpretation of SMBG data to assist in the management of patients with diabetes. This approach utilizes the following criteria: 1) Overall quality of glycemic control; 2) Hypoglycemia (frequency, severity, timing); 3) Hyperglycemia; 4) Variability; 5) Pattern analysis; and 6) Adequacy of monitoring. The “Pattern analysis” includes assessment of: Trends by date and by time of day; relationship of blood glucose to meals; post-prandial excursions; the effects of day of the week, and interactions between time of day and day of the week. Results: The asymmetrical distribution of blood glucose values makes it difficult to interpret the mean and standard deviation. Use of the median (50th percentile) and Inter-Quartile Range (IQR) overcomes these difficulties: IQR is the difference between the 75th and 25th percentiles. SMBG data can be used to predict the A1c level and indices of the risks of hyperglycemia and hypoglycemia. Conclusion: Given reliable measures of glucose variability, one can apply a strategy to progressively reduce glucose variability and then increase the intensity of therapy so as to reduce median blood glucose and hence A1c, while minimizing the risk of hypoglycemia.

[1]  R. Rizza,et al.  Measurements of Glucose Control , 1987, Diabetes Care.

[2]  Jennifer Y. Liu,et al.  Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. , 2001, The American journal of medicine.

[3]  D Rodbard,et al.  A pharmacodynamic approach to optimizing insulin therapy. , 1991, Computer methods and programs in biomedicine.

[4]  W. Herman,et al.  Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial. , 2006, Diabetes care.

[5]  B. Trigatti,et al.  Glucosamine-induced endoplasmic reticulum dysfunction is associated with accelerated atherosclerosis in a hyperglycemic mouse model. , 2006, Diabetes.

[6]  G. Alberti,et al.  Clinical Assessment of Metabolic Control in Insulin-dependent Diabetes Mellitus , 1980, Diabetes Care.

[7]  I. Hirsch,et al.  Should minimal blood glucose variability become the gold standard of glycemic control? , 2005, Journal of diabetes and its complications.

[8]  Irl B Hirsch,et al.  Glycemic variability: it's not just about A1C anymore! , 2005, Diabetes technology & therapeutics.

[9]  M. Braga,et al.  Exploratory Data Analysis , 2018, Encyclopedia of Social Network Analysis and Mining. 2nd Ed..

[10]  Robert A Gabbay,et al.  Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs. , 2005, Diabetes care.

[11]  William L Clarke,et al.  Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application. , 2005, Diabetes technology & therapeutics.

[12]  D. Rodbard,et al.  Personal Computer Programs to Assist with Self-Monitoring of Blood Glucose and Self-Adjustment of Insulin Dosage , 1986, Diabetes Care.

[13]  E K Shultz,et al.  Improved diabetic prognosis following telecommunication and graphical processing of diabetic data. , 1991, Proceedings. Symposium on Computer Applications in Medical Care.

[14]  R. Kalyani,et al.  Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. , 2006, JAMA.

[15]  A. Karter,et al.  Current evidence regarding the value of self-monitored blood glucose testing. , 2005, The American journal of medicine.

[16]  P L Miller,et al.  Combining statistical, rule-based, and physiologic model-based methods to assist in the management of diabetes mellitus. , 1990, Computers and biomedical research, an international journal.

[17]  J. Wojcicki,et al.  “J”-Index. A New Proposition of the Assessment of Current Glucose Control in Diabetic Patients , 1995, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[18]  D Rodbard,et al.  Ambulatory Glucose Profile: Representation of Verified Self-Monitored Blood Glucose Data , 1987, Diabetes Care.

[19]  M. Hanefeld,et al.  Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. , 2000, Diabetes care.

[20]  Jean-Paul Cristol,et al.  Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. , 2006, JAMA.

[21]  Wójcicki Jm,et al.  J"-index. A new proposition of the assessment of current glucose control in diabetic patients. , 1995 .

[22]  D. Rodbard Potential role of computers in clinical investigation and management of diabetes mellitus. , 1988, Diabetes care.

[23]  H. Yki-Järvinen,et al.  Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study , 2006, Diabetologia.

[24]  Ralph B D'Agostino,et al.  Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. , 2002, Diabetes care.

[25]  Michael Brownlee,et al.  The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes , 2007, Diabetes Care.

[26]  D. Cox,et al.  Numerical Estimation of HbA1c from Routine Self-Monitoring Data in People with Type 1 and Type 2 Diabetes Mellitus , 2004 .

[27]  Michael Brownlee,et al.  Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. , 2006, JAMA.

[28]  Daniel J Cox,et al.  Methods for quantifying self-monitoring blood glucose profiles exemplified by an examination of blood glucose patterns in patients with type 1 and type 2 diabetes. , 2002, Diabetes technology & therapeutics.

[29]  R. Marfella,et al.  Regression of Carotid Atherosclerosis by Control of Postprandial Hyperglycemia in Type 2 Diabetes Mellitus , 2004, Circulation.

[30]  M. Hanefeld,et al.  Postprandial glucose regulation and diabetic complications. , 2004, Archives of internal medicine.

[31]  J. Schlichtkrull,et al.  [M-VALUE, AN INDEX FOR BLOOD SUGAR CONTROL IN DIABETICS]. , 1964, Ugeskrift for laeger.

[32]  D Rodbard,et al.  Computer Simulation of Plasma Insulin and Glucose Dynamics After Subcutaneous Insulin Injection , 1989, Diabetes Care.